Post by FamiCord Group

We were honored to participate in the GNPI Congress 2026 in Mannheim (17–19 June), one of the leading events in neonatal and pediatric medicine. As part of the scientific program, FamiCord was invited to join an expert roundtable discussion focused on new cell therapies using mesenchymal stem cells (MSCs) in pediatric diseases. The session brought together international experts to discuss the latest clinical developments, challenges, and future directions in regenerative medicine for children. The growing interest in MSC-based therapies highlights the potential of advanced cellular treatments to address unmet medical needs in pediatric care. We are proud to contribute to these important conversations and support the advancement of innovative therapies that may improve outcomes for young patients worldwide. Thank you to the organizers and fellow experts for the inspiring exchange of knowledge and experience. #GNPI2026 #FamiCord #CellTherapy #MesenchymalStemCells #MSC #RegenerativeMedicine #Pediatrics #Neonatology #AdvancedTherapies #InnovationInHealthcare